Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future.

Rewers M, Gottlieb P.

Diabetes Care. 2009 Oct;32(10):1769-82. doi: 10.2337/dc09-0374. No abstract available.

2.

Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside.

Bresson D, von Herrath M.

Diabetes Care. 2009 Oct;32(10):1753-68. doi: 10.2337/dc09-0373. No abstract available.

3.

Antigen-based therapy for the treatment of type 1 diabetes.

Tian J, Kaufman DL.

Diabetes. 2009 Sep;58(9):1939-46. doi: 10.2337/db09-0451. No abstract available.

4.

Immune modulation for prevention of type 1 diabetes mellitus.

Raz I, Eldor R, Naparstek Y.

Trends Biotechnol. 2005 Mar;23(3):128-34. Review.

PMID:
15734555
5.

Immunomodulatory therapy of human type 1 diabetes: lessons from the mouse.

Palmer JP.

J Clin Invest. 2001 Jul;108(1):31-3. No abstract available.

6.

Type 1 diabetes vaccine development: animal models vs. humans.

Boettler T, von Herrath M.

Hum Vaccin. 2011 Jan 1;7(1):19-26. Epub 2011 Jan 1. Review.

PMID:
21157185
7.

Antigen-specific immunotherapy: oral tolerance and subcutaneous immunization in the treatment of insulin-dependent diabetes.

Muir A, Schatz D, Maclaren N.

Diabetes Metab Rev. 1993 Dec;9(4):279-87. Review. No abstract available.

PMID:
7924825
8.

Immunotherapy of type 1 diabetes mellitus.

Chatenoud L.

Curr Dir Autoimmun. 2001;4:333-50. Review. No abstract available.

PMID:
11569410
9.

Animal models of type I (insulin-dependent) diabetes mellitus.

CheŇ£a D.

J Pediatr Endocrinol Metab. 1998 Jan-Feb;11(1):11-9. Review.

PMID:
9642624
10.

When will immunomodulation for the prevention of type 1 diabetes be a reality?

Leech NJ.

Diabet Med. 2003 Jan;20 Suppl 1:10-3. No abstract available.

PMID:
12647834
11.

Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.

Johnson MC, Wang B, Tisch R.

Hum Vaccin. 2011 Jan 1;7(1):27-36. Epub 2011 Jan 1. Review.

12.

Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease.

Bowman MA, Leiter EH, Atkinson MA.

Immunol Today. 1994 Mar;15(3):115-20. Review.

PMID:
8172643
13.

Current and past prevention and intervention trials in type 1 diabetes.

Staeva T.

Novartis Found Symp. 2008;292:99-109; discussion 109-12, 122-9, 202-3.

PMID:
19203095
14.

Immunotherapeutic approaches to prevent, ameliorate, and cure type 1 diabetes.

Aly T, Devendra D, Eisenbarth GS.

Am J Ther. 2005 Nov-Dec;12(6):481-90. Review.

PMID:
16280641
15.

IL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetes.

Diaz-de-Durana Y, Lau J, Knee D, Filippi C, Londei M, McNamara P, Nasoff M, DiDonato M, Glynne R, Herman AE.

PLoS One. 2013 Oct 24;8(10):e78483. doi: 10.1371/journal.pone.0078483. eCollection 2013.

16.

Immunotherapy for the prevention and treatment of type 1 diabetes.

Goudy KS, Tisch R.

Int Rev Immunol. 2005 Sep-Dec;24(5-6):307-26. Review.

PMID:
16318984
17.

Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation.

Schneider DA, Kretowicz AM, von Herrath MG.

Diabetes Obes Metab. 2013 Jul;15(7):581-92. doi: 10.1111/dom.12046. Epub 2013 Jan 21. Review.

PMID:
23194064
18.

Immunotherapy in type I diabetes. Approaches to prevention and treatment.

Colman PG, Eisenbarth GS.

Postgrad Med. 1987 May 1;81(6):146-55.

PMID:
3554198
19.

Targeting proinsulin-reactive CD8+ T cells: a new direction for type 1 diabetes treatment.

Abreu JR, Roep BO.

Expert Rev Clin Immunol. 2013 Nov;9(11):1001-3. doi: 10.1586/1744666X.2013.852958. No abstract available.

PMID:
24168405
20.

Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials.

Staeva TP, Chatenoud L, Insel R, Atkinson MA.

Diabetes. 2013 Jan;62(1):9-17. doi: 10.2337/db12-0562. Review. No abstract available.

Supplemental Content

Support Center